Third or Fourth Place in the Race? No Problem – The Case for More Trials Using Darolutamide for Patients with Prostate Cancer

non-metastatic (M0) castration-resistant prostate cancer, ARAMIS trial, PEACE-1 trial, ARASENS trial, abiraterone, enzalutamide, apalutamide, Darolutamide in Prostate Cancer, Evan Yu.

Read the full article here

Related Articles